Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yuanze Du, Yi Wang, Ting Zhang, Juanjuan Li, Hewei Song, Yuanyuan Wang, Yifei Xu, Jingwen Cui, Ming Yang, Zengwu Wang, Xiuyun Wu & Chunping Wang. (2023) Economic evaluations of 13-valent pneumococcal conjugate vaccine: a systematic review. Expert Review of Vaccines 22:1, pages 193-206.
Read now
Read now
Derek Lytle, Ana Gabriela Grajales Beltrán, Johnna Perdrizet, Nassim Ait Yahia, Alejandro Cane, Benjamin Yarnoff & Ruth Chapman. (2023) Cost-effectiveness analysis of PCV20 to prevent pneumococcal disease in the Canadian pediatric population. Human Vaccines & Immunotherapeutics 19:2.
Read now
Read now
Articles from other publishers (5)
M. Sakil Syeed, Priyanka Ghule, Lan M. Le, Sajesh K. Veettil, Emily K. Horn, Johnna Perdrizet, Matt Wasserman, Ammarin Thakkinstian & Nathorn Chaiyakunapruk. (2023) Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-Effectiveness Studies. Value in Health 26:4, pages 598-611.
Crossref
Crossref
Mariska M. J. Scheffer, Luc E. Coffeng & James F. O’Mahony. (2023) Appropriateness of strategy comparisons in cost-effectiveness analyses of infant pneumococcal vaccination: a systematic review. International Journal of Technology Assessment in Health Care 39:1.
Crossref
Crossref
Mark H. Rozenbaum, Johnna Perdrizet, Xiuyan Li, Matt D. Wasserman, Lindsay R. Grant, Kyla Hayford & Raymond A. Farkouh. (2022) A Response to: Letter to the Editor Regarding ‘Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age’. Infectious Diseases and Therapy 12:1, pages 295-298.
Crossref
Crossref
Matt D. Wasserman, Johnna Perdrizet, Lindsay Grant, Kyla Hayford, Shubhra Singh, Paranjoy Saharia, Emily K. Horn & Raymond A. Farkouh. (2021) Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age. Infectious Diseases and Therapy 10:4, pages 2701-2720.
Crossref
Crossref
Johnna Perdrizet, Emily K. Horn, Winniefer Nua, Judith Perez-Peralta, Jennifer Nailes, Jaime Santos & Anna Ong-Lim. (2021) Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants. Infectious Diseases and Therapy 10:4, pages 2625-2642.
Crossref
Crossref